Stock soars for Cincinnati firm that could help combat coronavirus 
 The value of Meridian Bioscience Inc. stock soared by nearly 40% on Monday on news that one of the firm’s test kits is being used by diagnostic companies and laboratories in China to develop fast and accurate screening assays for the deadly new strain of coronavirus.

Stock in Newtown-based Meridian (Nasdaq: VIVO) was trading as high as $13.31 today, up $3.78 from a previous close of $9.53. 

Shares were trading around $11.63 this afternoon. That was up $2.10, or more than 22%, from the previous…